Preliminary results of deferoxamine and L1 treatment of spinal cord ischemia.
Reuter
D G
DG
Hillenbrand Biomedical Engineering Center, Purdue University, West Lafayette, IN 47907-1293, USA.
Tacker
W A
WA
Babbs
C F
CF
Badylak
S F
SF
Voorhees
W D
WD
Konrad
P E
PE
D000818:Animals; D000077543:Deferiprone; D003676:Deferoxamine / Q000627:therapeutic use*; D004285:Dogs; D007502:Iron Chelating Agents / Q000627:therapeutic use*; D007511:Ischemia / Q000188:drug therapy*; D011728:Pyridones / Q000627:therapeutic use*; D015427:Reperfusion Injury / Q000517:prevention & control; D013116:Spinal Cord / Q000098:blood supply* / Q000473:pathology
D007502:Iron Chelating Agents; D011728:Pyridones; D000077543:Deferiprone; D003676:Deferoxamine